Skip to main content

Articles

Page 71 of 76

  1. To detect the expression of isocitrate dehydrogenase 1 (IDH1) and transformation-related protein 53 (p53) in osteosarcoma and analyze the correlation between them and the clinico-pathological features.

    Authors: Xiang Hu, Ai-Xi Yu, Bai-Wen Qi, Tao Fu, Gang Wu, Min Zhou, Jun Luo and Jun-Hua Xu
    Citation: Journal of Experimental & Clinical Cancer Research 2010 29:43
  2. Calcifying epithelioma of Malherbe, or Pilomatricoma, is considered an uncommon cutaneous neoplasia, normally occurring in children as a solitary, firm, asymptomatic, hard, subcutaneous, slowly growing nodule ...

    Authors: Francesco M Solivetti, Fulvia Elia, Alessandra Drusco, Chiara Panetta, Ada Amantea and Aldo Di Carlo
    Citation: Journal of Experimental & Clinical Cancer Research 2010 29:42
  3. In our previous study, it was well defined that IGFBP7 was an important tumor suppressor gene in colorectal cancer (CRC). We aimed to uncover the downstream molecules responsible for IGFBP7's behaviour in this st...

    Authors: Wenjing Ruan, Yinghong Wang, Yu Ma, Xiaoming Xing, Jie Lin, Jing Cui and Maode Lai
    Citation: Journal of Experimental & Clinical Cancer Research 2010 29:41
  4. The erbB receptors and their ligands are involved in the pathogenesis and progression of oral squamous cell carcinoma (OSCC). Although EGFR and Her-2 are frequently overexpressed in OSCC, few studies evaluated...

    Authors: Vanessa F Bernardes, Frederico O Gleber-Netto, Sílvia F Sousa, Tarcília A Silva and Maria Cássia F Aguiar
    Citation: Journal of Experimental & Clinical Cancer Research 2010 29:40
  5. Definitions of basal-like breast cancer phenotype vary, and microarray-based expression profiling analysis remains the gold standard for the identification of these tumors. Immunohistochemical identification o...

    Authors: Radzislaw Kordek, Piotr Potemski, Renata Kusinska, Elzbieta Pluciennik and Andrzej Bednarek
    Citation: Journal of Experimental & Clinical Cancer Research 2010 29:39
  6. The objective of this study was to evaluate the efficacy and safety of pemetrexed plus cisplatin/carboplatin in locally advanced or metastatic non-small cell lung cancer (NSCLC) patients previously treated wit...

    Authors: Guan-Zhong Zhang, Shun-Chang Jiao and Zhao-Ting Meng
    Citation: Journal of Experimental & Clinical Cancer Research 2010 29:38
  7. To investigate whether dendritic cell (DC) precursors, recruited by injection of chemokine ligand 3 (CCL3) and CCL20, induce anti-tumor immunity against gastric cancer induced by a DC vaccine expressing melanoma ...

    Authors: Songbing He, Liang Wang, Yugang Wu, Dechun Li and Yanyun Zhang
    Citation: Journal of Experimental & Clinical Cancer Research 2010 29:37
  8. Analysis of gene expression and gene mutation may add information to be different from ordinary pathological tissue diagnosis. Since samples obtained endoscopically are very small, it is desired that more sens...

    Authors: Koji Nonogaki, Akihiro Itoh, Hiroki Kawashima, Eizaburo Ohno, Takuya Ishikawa, Hiroshi Matsubara, Yuya Itoh, Yosuke Nakamura, Masanao Nakamura, Ryoji Miyahara, Naoki Ohmiya, Masatoshi Ishigami, Yoshiaki Katano, Hidemi Goto and Yoshiki Hirooka
    Citation: Journal of Experimental & Clinical Cancer Research 2010 29:36
  9. This study explored the response of nasopharyngeal carcinoma cells to TGF-β1-induced growth suppression and investigated the roles of the TGF-β/Smad signaling pathway in nasopharyngeal carcinoma cells.

    Authors: Jian Xiao, Qi Xiang, Ye-Chen Xiao, Zhi-Jian Su, Zhi-Feng Huang, Qi-Hao Zhang, Yi Tan, Xiao-Kun Li and Ya-Dong Huang
    Citation: Journal of Experimental & Clinical Cancer Research 2010 29:35
  10. PIK3CA is one of the genes most frequently mutated in human cancers and it is a potential target for personalized therapy. The aim of this study was to assess the frequency and type of PIK3CA mutations in gastric...

    Authors: Stefano Barbi, Ivana Cataldo, Giovanni De Manzoni, Samantha Bersani, Simona Lamba, Silvia Mattuzzi, Alberto Bardelli and Aldo Scarpa
    Citation: Journal of Experimental & Clinical Cancer Research 2010 29:32
  11. In spite of recent advances in diagnostic and therapeutic measures, the prognosis of hepatocellular carcinoma (HCC) patients remains poor. Therefore, it is crucial to understand what factors are involved in pr...

    Authors: Ke Zheng, Hong-Yuan Li, Xin-Liang Su, Xiao-Yi Wang, Tian Tian, Fan Li and Guo-Sheng Ren
    Citation: Journal of Experimental & Clinical Cancer Research 2010 29:31
  12. The past two decades have witnessed an increasing appreciation of the role of the tumor microenvironment, of genetic and epigenetic alterations in normal cells adjacent to tumors and of the migration of normal...

    Authors: Razvan T Radulescu
    Citation: Journal of Experimental & Clinical Cancer Research 2010 29:30
  13. MicroRNAs are non-coding RNA molecules that posttranscriptionally regulate expression of target genes and have been implicated in the progress of cancer proliferation, differentiation and apoptosis. The aim of...

    Authors: Bao Song, Chuanxi Wang, Jie Liu, Xingwu Wang, Liyan Lv, Ling Wei, Li Xie, Yan Zheng and Xianrang Song
    Citation: Journal of Experimental & Clinical Cancer Research 2010 29:29
  14. The secreted protein acidic and rich in cysteine (SPARC) plays a pivotal role in regulating cell-matrix interactions and tumor angiogenesis, proliferation, and migration. Detection of SPARC gene methylation may b...

    Authors: Jun Gao, Jian Song, Haojie Huang, Zhaoshen Li, Yiqi Du, Jia Cao, Minghui Li, Shunli Lv, Han Lin and Yanfang Gong
    Citation: Journal of Experimental & Clinical Cancer Research 2010 29:28
  15. Circulating bone marrow-derived endothelial progenitor cells (EPCs) have been reported to participate in tumor angiogenesis and growth; however, the role of circulating EPCs in tumor progression is controversi...

    Authors: Yajuan Su, Lei Zheng, Qian Wang, Weiqi Li, Zhen Cai, Shilong Xiong and Jie Bao
    Citation: Journal of Experimental & Clinical Cancer Research 2010 29:27
  16. Wnt inhibitory factor-1(WIF-1) acts as a Wnt-antagonists and tumor suppressor, but hypermethylation of WIF-1 gene promoter and low expression activate Wnt signaling aberrantly and induce the development of var...

    Authors: Zhuanyi Yang, Ying Wang, Jiasheng Fang, Fenghua Chen, Jinfang Liu, Jun Wu and Yanjin Wang
    Citation: Journal of Experimental & Clinical Cancer Research 2010 29:26
  17. Giant cell tumor is an infrequent and unpredictable bony lesion. Although numerous attempts have been made to predict the behaviour of GCT, there are no definite biological or histological parameters to determ...

    Authors: Faisham W Ismail, Aminudin M Shamsudin, Zulmi Wan, Salzihan M Daud and Mutum S Samarendra
    Citation: Journal of Experimental & Clinical Cancer Research 2010 29:25
  18. Perineural invasion is a common path for cholangiocarcinoma (CCA) metastasis, and it is highly correlated with postoperative recurrence and poor prognosis. It is often an early event in a disease that is commo...

    Authors: Fang-Zhen Shen, Bing-Yuan Zhang, Yu-Jie Feng, Zhuo-Xia Jia, Bing An, Chang-Chang Liu, Xi-Yun Deng, Anil D Kulkarni and Yun Lu
    Citation: Journal of Experimental & Clinical Cancer Research 2010 29:24
  19. Anti-HER-2 antibodies targeting distinct epitopes have different biological functions on cancer cells. In a previous study, we demonstrated that anti-HER-2 engineering antibody ChA21 was able to bind to subdom...

    Authors: AnLi Zhang, Hua Xue, XiaoGuang Ling, Yi Gao, Feng Yang, LianSheng Cheng, Jing Liu and Qiang Wu
    Citation: Journal of Experimental & Clinical Cancer Research 2010 29:23
  20. It is known that thiazolidinediones are involved in regulating the expression of various genes, including the vascular endothelial growth factor (VEGF) gene via peroxisome proliferator-activated receptor γ (PP...

    Authors: Takayuki Yoshizaki, Wataru Motomura, Sachie Tanno, Shima Kumei, Yumiko Yoshizaki, Satoshi Tanno and Toshikatsu Okumura
    Citation: Journal of Experimental & Clinical Cancer Research 2010 29:22
  21. Taurolidine (TRD) represents an anti-infective substance with anti-neoplastic activity in many malignant cell lines. So far, the knowledge about the cell death inducing mechanisms and pathways activated by TRD...

    Authors: Ansgar M Chromik, Adrien Daigeler, Daniel Bulut, Annegret Flier, Christina May, Kamran Harati, Jan Roschinsky, Dominique Sülberg, Peter R Ritter, Ulrich Mittelkötter, Stephan A Hahn and Waldemar Uhl
    Citation: Journal of Experimental & Clinical Cancer Research 2010 29:21
  22. To retrospectively review the incidence, treatment efficacy, we followed up newly diagnosed chronic myelogenous leukemia (CML) patients residing in Shanghai during 2001-2006.

    Authors: Ai-Hua Wang, Yan-Yan Wang, Yu Yao, Zi-Zhen Xu, Li Zhou, Li Wang, Li Zhang, Yu Chen, Zhi-Xiang Shen, Jiong Hu and Jun-Min Li
    Citation: Journal of Experimental & Clinical Cancer Research 2010 29:20
  23. Hereditary hemochromatosis (HH) is an autosomal recessive disorder mainly associated with homozygosity for the C282Y and H63D mutations in the hemochromatosis (HFE) gene. The reports about the C282Y and H63D m...

    Authors: Fei Jin, Li-Shuai Qu and Xi-Zhong Shen
    Citation: Journal of Experimental & Clinical Cancer Research 2010 29:18
  24. To better search for potential markers for hepatocellular carcinoma (HCC) invasion and metastasis, proteomic approach was applied to identify potential metastasis biomarkers associated with HCC.

    Authors: Long Wu, Chun-Wei Peng, Jin-Xuan Hou, Yan-Hua Zhang, Chuang Chen, Liang-Dong Chen and Yan Li
    Citation: Journal of Experimental & Clinical Cancer Research 2010 29:17
  25. The chemokine receptors CXCR4 and CCR7 play an important role in cancer invasion and metastasis. This study investigated the expression of CXCR4, CCR7, CXCL12, CCL21, and EGFR to illustrate the role of these b...

    Authors: Yixin Liu, Ru Ji, Jingyong Li, Qiang Gu, Xiulan Zhao, Tao Sun, Jinjing Wang, Jiangbo Li, Qiuyue Du and Baocun Sun
    Citation: Journal of Experimental & Clinical Cancer Research 2010 29:16
  26. The combination of gemcitabine (GEM) and S-1, an oral 5-fluorouracil (5-FU) derivative, has been shown to be a promising regimen for patients with unresectable pancreatic cancer.

    Authors: Bunzo Nakata, Ryosuke Amano, Shigetomi Nakao, Tatsuro Tamura, Osamu Shinto, Toshiki Hirakawa, Yoshihiro Okita, Nobuya Yamada and Kosei Hirakawa
    Citation: Journal of Experimental & Clinical Cancer Research 2010 29:15
  27. Genome-wide RNA interference screening study revealed that loss of expression of insulin-like growth factor binding protein 7 (IGFBP7) is a critical step in development of a malignant melanoma (MM), and this s...

    Authors: Rong-Yi Chen, Hong-Xiang Chen, Jia-Xi Lin, Wei-Bing She, Ping Jiang, Li Xu and Ya-Ting Tu
    Citation: Journal of Experimental & Clinical Cancer Research 2010 29:13
  28. Prospective, randomized, pilot clinical study was conducted to evaluate the beneficial effects of inositol hexaphosphate (IP6) + Inositol in breast cancer patients treated with adjuvant therapy.

    Authors: Ivan Bačić, Nikica Družijanić, Robert Karlo, Ivan Škifić and Stjepan Jagić
    Citation: Journal of Experimental & Clinical Cancer Research 2010 29:12
  29. The Sézary syndrome is an aggressive leukemic form of cutaneous T cell lymphoma and there is no cure of this disease. Until now there is no true animal model for Sézary syndrome, by which new drugs against the...

    Authors: Udo Doebbeling
    Citation: Journal of Experimental & Clinical Cancer Research 2010 29:11
  30. SIAH proteins are the human members of an highly conserved family of E3 ubiquitin ligases. Several data suggest that SIAH proteins may have a role in tumor suppression and apoptosis. Previously, we reported th...

    Authors: Heriberto Bruzzoni-Giovanelli, Plinio Fernandez, Lucía Veiga, Marie-Pierre Podgorniak, Darren J Powell, Marco M Candeias, Samia Mourah, Fabien Calvo and Mónica Marín
    Citation: Journal of Experimental & Clinical Cancer Research 2010 29:10
  31. Accelerated hypofractionation is an attractive approach for adjuvant whole breast radiotherapy. In this study we evaluated the adverse effects at least 3 years post an accelerated hypofractionated whole breast...

    Authors: Paola Pinnarò, Antonella Soriani, Valeria Landoni, Carolina Giordano, Maria Papale, Annelisa Marsella, Laura Marucci, Giorgio Arcangeli and Lidia Strigari
    Citation: Journal of Experimental & Clinical Cancer Research 2010 29:9
  32. Survivin is known playing a role in drug resistance. However, its role in bortezomib-mediated inhibition of growth and induction of apoptosis is unclear. There are conflicting reports for the effect of bortezo...

    Authors: Xiang Ling, Diane Calinski, Asher A Chanan-Khan, Muxiang Zhou and Fengzhi Li
    Citation: Journal of Experimental & Clinical Cancer Research 2010 29:8
  33. The knowledge of Epidermal growth factor receptor (EGFR) expression in metastases of NSCLC was limited. In receptor-mediated targeted nuclide radiotherapy, tumor cells are killed with delivered radiation and t...

    Authors: Chuangzhou Rao, Qiongge Hu, Jianhua Ma, Jian Li, Chen Zhang, Li Shen and Qichun Wei
    Citation: Journal of Experimental & Clinical Cancer Research 2010 29:7
  34. The Tientsin Albino 2 (TA2) mouse is an inbred strain originating from the Kunming strain. It has a high incidence of spontaneous breast cancer without the need for external inducers or carcinogens. Until now,...

    Authors: Yanjun Gu, Shiwu Zhang, Qiang Wu, Shaoyan Xu, Yanfen Cui, Zhengduo Yang, Xiulan Zhao and Baocun Sun
    Citation: Journal of Experimental & Clinical Cancer Research 2010 29:6
  35. Lymph node status is an important prognostic factor and a criterion for adjuvant therapy in uterine cancers. While detection of micrometastases by ultrastaging techniques is correlated to prognosis in several ...

    Authors: Corinne Bézu, Charles Coutant, Marcos Ballester, Jean-Guillaume Feron, Roman Rouzier, Serge Uzan and Emile Daraï
    Citation: Journal of Experimental & Clinical Cancer Research 2010 29:5
  36. Endometriosis is a common disease characterized by the presence of a functional endometrium outside the uterine cavity, causing pelvic pain, dysmenorrheal, and infertility. This disease has been associated to ...

    Authors: Daniel E Machado, Plínio T Berardo, Celia Y Palmero and Luiz E Nasciutti
    Citation: Journal of Experimental & Clinical Cancer Research 2010 29:4
  37. bFGF is an important growth factor for glioma cell proliferation and invasion, while connexin 43 is implicated in the suppression of glioma growth. Correspondingly, gliomas have been shown to have reduced, or ...

    Authors: Biao Zhang, Xuequan Feng, Jinhuan Wang, Xinnu Xu, Hongsheng Liu and Na Lin
    Citation: Journal of Experimental & Clinical Cancer Research 2010 29:3
  38. Renal cell carcinoma (RCC) is a cancer of increasing incidence and mortality. Currently, there are no immunohistochemical prognostic markers for RCCs in routine use. The aim of this study was to examine for th...

    Authors: Hanna Ronkainen, Saila Kauppila, Pasi Hirvikoski and Markku H Vaarala
    Citation: Journal of Experimental & Clinical Cancer Research 2010 29:2
  39. The aim of this study is to examine the safety and distribution of Ad-EGFP-MDR1, an adenovirus encoding human multidurg resistance gene (human MDR1), in the mice colon carcinoma model.

    Authors: ZhenZhen Zhao, Wei Liu, YuXi Su, Jin Zhu, GaiHuan Zheng, Qing Luo and XianQing Jin
    Citation: Journal of Experimental & Clinical Cancer Research 2010 29:1
  40. Epigenetic silencing of tumor suppressor genes associated with promoter methylation is considered to be a hallmark of oncogenesis. RASSF1A is a candidate tumor suppressor gene which was found to be inactivated...

    Authors: Tao Wang, Hongli Liu, Yeshan Chen, Wei Liu, Jing Yu and Gang Wu
    Citation: Journal of Experimental & Clinical Cancer Research 2009 28:160
  41. The results from the published studies on the association between hypoxia-inducible factor -1α (HIF-1α) polymorphisms and cancer risk are conflicting. In this meta-analysis, we aimed to investigate the associatio...

    Authors: Tongfeng Zhao, Jing Lv, Jiangpei Zhao and Marius Nzekebaloudou
    Citation: Journal of Experimental & Clinical Cancer Research 2009 28:159
  42. Twist is a basic helix-loop-helix (bHLH) transcriptional factor that has been identified to play an important role in epithelial-mesenchymal transition (EMT)-mediated metastasis through the regulation of E-cad...

    Authors: Ken Sasaki, Shoji Natsugoe, Sumiya Ishigami, Masataka Matsumoto, Hiroshi Okumura, Tetsuro Setoyama, Yasuto Uchikado, Yoshiaki Kita, Kiyokazu Tamotsu, Akihiko Sakamoto, Tetsuhiro Owaki and Takashi Aikou
    Citation: Journal of Experimental & Clinical Cancer Research 2009 28:158
  43. Despite the fact that genetic counseling in oncology provides information regarding objective risks, it can be found a contrast between the subjective and objective risk.

    Authors: Anita Caruso, Cristina Vigna, Bruna Marozzo, Fabio M Sega, Isabella Sperduti, Francesco Cognetti and Antonella Savarese
    Citation: Journal of Experimental & Clinical Cancer Research 2009 28:157
  44. CENP-E, one of spindle checkpoint proteins, plays a crucial role in the function of spindle checkpoint. Once CENP-E expression was interrupted, the chromosomes can not separate procedurally, and may result in ...

    Authors: Zijie Liu, Kang Ling, Xia Wu, Ju Cao, Bin Liu, Suyan Li, Qiong Si, Yan Cai, Chen Yan, Yan Zhang and Yaguang Weng
    Citation: Journal of Experimental & Clinical Cancer Research 2009 28:156
  45. Bladder cancer is the ninth most common malignancy in the world. Successful clinical management remains a challenge. In order To search for novel targeted and efficacious treatment, we sought to investigate an...

    Authors: Wei Tang, Yunfeng He, Shengcai Zhou, Yongping Ma and Geli Liu
    Citation: Journal of Experimental & Clinical Cancer Research 2009 28:155

Annual Journal Metrics

  • 2022 Citation Impact
    11.3 - 2-year Impact Factor
    11.5 - 5-year Impact Factor
    1.870 - SNIP (Source Normalized Impact per Paper)
    2.413 - SJR (SCImago Journal Rank)

    2023 Speed
    4 days submission to first editorial decision for all manuscripts (Median)
    100 days submission to accept (Median)

    2023 Usage 
    3,003,080 downloads
    3,022 Altmetric mentions